Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

Sight Sciences (SGHT) Shares Outstanding (Weighted Average) (2020 - 2026)

Sight Sciences has reported Shares Outstanding (Weighted Average) over the past 6 years, most recently at $52.1 million for Q4 2025.

  • For Q4 2025, Shares Outstanding (Weighted Average) rose 4.02% year-over-year to $52.1 million; the TTM value through Dec 2025 reached $52.1 million, up 4.02%, while the annual FY2025 figure was $52.1 million, 4.02% up from the prior year.
  • Shares Outstanding (Weighted Average) for Q4 2025 was $52.1 million at Sight Sciences, roughly flat from $52.4 million in the prior quarter.
  • Over five years, Shares Outstanding (Weighted Average) peaked at $52.4 million in Q3 2025 and troughed at $9.5 million in Q1 2021.
  • A 5-year average of $43.9 million and a median of $48.6 million in 2023 define the central range for Shares Outstanding (Weighted Average).
  • Biggest five-year swings in Shares Outstanding (Weighted Average): skyrocketed 399.82% in 2022 and later rose 1.63% in 2023.
  • Year by year, Shares Outstanding (Weighted Average) stood at $26.7 million in 2021, then surged by 78.98% to $47.8 million in 2022, then increased by 1.63% to $48.6 million in 2023, then increased by 3.1% to $50.1 million in 2024, then grew by 4.02% to $52.1 million in 2025.
  • Business Quant data shows Shares Outstanding (Weighted Average) for SGHT at $52.1 million in Q4 2025, $52.4 million in Q3 2025, and $51.6 million in Q2 2025.